Womens Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteopor
Women's Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need
will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets
Summary
"Women's Health Therapeutics Market to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in Menopause and Osteoporosis", provides in-depth analysis of unmet needs, drivers and barriers that impact the global women's health market. The report analyzes the markets for women's health in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, prices and volumes are forecast until 2016 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.
Scope
The scope of this report includes:
Annualized market data for the women's health market from 2001 to 2009, forecast forward to 2016.
Analysis of the leading therapeutic segments, including osteoporosis, hormone therapy for menopause, endometriosis, women's infertility and polycistic ovarian syndrome.
Analysis of the women's health market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain and Japan.
Market characterization of the women's health market, including market size, annual cost of therapy, sales volume and treatment usage patterns.
Key drivers and barriers that have a significant impact on the market.
Coverage of pipeline molecules in various phases of drug development.
Competitive benchmarking of leading companies. The key companies studied in this report are Merck, Pfizer, Johnson & Johnson, Teva Pharmaceuticals and Bayer-Schering Pharma.
Key M&A activities, licensing agreements, that have taken place in 2009 in the global blood disorders market.
For more information please contact: http://www.aarkstore.com/reports/Womens-Health-Therapeutics-Analysis-and-Market-Forecasts-to-2016-High-Unmet-Need-will-Drive-the-Uptake-of-Novel-Drugs-in-the-Menopause-and-Osteoporosis-Markets-61582.html
From:AarkstoreEnterprise
Contact: jessica
Email:jessica@aarkstore.com
Contact:+918149852585
URL: www.aarkstore.com
Womens Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteopor
By: Pushpanjali
Removing Intellectual Property Rights Will Only Worsen Africa's Healthcare Crisis Herbal beverages Fat Burning Furnace - Health Risks of Fat 7 Tips For Better Sleep Health And Beauty Effects Of Deep Sea Black Mud the best way to reduce your weight, EAT Healthy..!! Perfect Bath And Body Care With Deep Sea Cosmetics Bath And Body Packages Sleep Apnea Treatment - Are There Cpap Alternatives? Info On The Most Effective Ways To Body Build - The Best Routines The Best Type Of Exercises For Body Building To Have Firm Muscles And A Defined Look Leading A Healthy Lifestyle After 55 How Electronic Or E- Cigarettes Work Symptoms And Treatment Of Anxiety Disorder
Womens Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteopor Anaheim